This story was originally posted on Dec. 9
The National Institutes of Health recently awarded CustomArray nearly $200,000 to develop its padlock-probe array technology for use in microRNA detection, with an eye on eventually making the platform available to support oncology testing.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
